Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfimeprase for occluded central venous catheters
NCT00346424Phase 3Completed
- Sponsor
- Oruka Therapeutics
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of alfimeprase in central venous catheter occlusion, sponsored by Oruka Therapeutics. Started Sep 2005; status: completed.
02
Drugs
alfimeprase
03
Conditions
central venous catheter occlusion
Beyond the preview
Go deeper on NCT00346424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346424.